Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

"Adverse Event"

Performance/Reporting Period
2020
QDM Datatype (QDM Version 5.4):

Data elements that meet criteria using this datatype should document the Adverse Event and its corresponding value set.

Data Elements defined by this QDM Datatype:
QDM Attributes

authorDateTime

The time the data element was entered into the clinical software. Note, some datatypes include both Relevant Time and Author dateTime attributes. The purpose is to accommodate Author dateTime if the actual start and stop times are not available when evaluating for feasibility, and also to allow specification of a time for Negation Rationale.

facilityLocation

The particular locations in a facility in which the diagnostic study or encounter occurs or occurred. Examples include, but are not limited to, intensive care units (ICUs), non- ICUs, burn critical-care unit, neonatal ICU, and respiratory-care unit. Each Encounter, Performed may have 1 or more locations. For example, a patient treated in multiple locations during an individual encounter might be expressed as: Encounter, Performed: Inpatient Admission, ICU (location period), Non-ICU Admission (location period), Rehab (location period). Facility Location (singular) is used for Adverse Event; Diagnostic Study, Performed; Encounter, Order; Encounter, Recommended.

relevantPeriod

Relevant Period addresses the time between the start of an action to the end of an action. Each datatype using relevant period defines specific definitions for the start and stop time for the action listed.

severity

Indicates the intensity of the specified datatype (e.g., persistent, moderate, or severe).

type

The characterization of the reaction (e.g., hypersensitivity, rash, gastroenteric symptoms, etc.).
Last Updated: Jul 08, 2021